MV-CHIK
AXP000208.1 · Vaccine
- Platform
- measles virus (Schwarz vaccine strain) vector
- Targets
- CHIKV C-E3-E2-6K-E1
- Originator
- Institut Pasteur / Themis Bioscience
- Sponsor
- Merck Sharp & Dohme
Names
Virus
- Role
- Vaccine vector
- Family
- Paramyxoviridae
- Virus
- measles morbillivirus (NCBI Taxonomy 11234)
- Strain
- Schwarz vaccine strain
- Replication
- replicating
- Modifications
- additional transcription unit encoding the chikungunya virus structural proteins C, E3, E2, 6K and E1
- Transgenes
- CHIKV C, CHIKV E3, CHIKV E2, CHIKV 6K, CHIKV E1
- Route
- intramuscular
- Source
- evidence
Approvals
No regulatory approval recorded.
Clinical trials (4)
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions |
|---|---|---|---|---|---|---|---|
| NCT03807843 | Chikungunya Vaccine (V184) Study in Previously Exposed Adults (V184-006) | Completed | Phase 2 | 2019-07-16 | 2021-05-13 | 41 | Chikungunya Virus Infection |
| NCT03635086 | Safety, Tolerability and Long-term Immunogenicity of Different Formulations of a Chikungunya Vaccine (V184-005) | Completed | Phase 2 | 2018-08-22 | 2019-01-25 | 60 | Chikungunya Virus Infection |
| NCT03101111 | Study of a Live Attenuated Chikungunya Vaccine in a Previously Epidemic Area | Completed | Phase 2 | 2017-08-09 | 2019-04-02 | 34 | Chikungunya |
| NCT02861586 | Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine | Completed | Phase 2 | 2016-08-17 | 2017-09-01 | 263 | Chikungunya Virus Infection |
Recent changes
No changes recorded in its trials yet.
Clinical papers
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 41313671 | A Phase 1 Double-Blinded Trial to Evaluate Safety, Immunogenicity, and Dosing of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults. | The Journal of infectious diseases | 2026 | name in title: MV-CHIK |
| PMID 37726181 | A measles virus-based vaccine induces robust chikungunya virus-specific CD4+ T-cell responses in a phase II clinical trial. | Vaccine | 2023 | name in abstract: MV-CHIK |
| PMID 34582377 | Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccine. | JCI insight | 2021 | cited by trial NCT02861586 |
| PMID 31828322 | Analysis of Humoral Immune Responses in Chikungunya Virus (CHIKV)-Infected Patients and Individuals Vaccinated With a Candidate CHIKV Vaccine. | The Journal of infectious diseases | 2020 | name in abstract: MV-CHIK |
| PMID 30409443 | Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial. | Lancet (London, England) | 2019 | cited by trial NCT02861586 |
| PMID 25739878 | Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. | The Lancet. Infectious diseases | 2015 | cited by trial NCT03635086 |
Other papers
Preclinical studies, reviews and other papers that name it.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 42506635 | Mapping Human Clinical Evidence for Chikungunya Vaccines: A Scoping Review of Immunogenicity, Durability, and Safety. | Vaccines | 2026 | name in abstract: MV-CHIK |
| PMID 39104592 | Chikungunya virus vaccine: a decade of progress solving epidemiological dilemma, emerging concepts, and immunological interventions. | Frontiers in microbiology | 2024 | name in abstract: MV-CHIK |
| PMID 39340001 | Immunogenicity and Safety of Chikungunya Vaccines: A Systematic Review and Meta-Analysis. | Vaccines | 2024 | name in abstract: MV-CHIK |
| PMID 39467413 | Chikungunya vaccine development, challenges, and pathway toward public health impact. | Vaccine | 2024 | name in abstract: MV-CHIK |
| PMID 36243743 | Versatility of live-attenuated measles viruses as platform technology for recombinant vaccines. | NPJ vaccines | 2022 | name in abstract: MV-CHIK |
Unconfirmed matches (7)
Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 42731393 | NMR relaxation dispersion reveals an order of magnitude range of acid loop motions in protein tyrosine phosphatase 1B. | Journal of magnetic resonance (San Diego, Calif. : 1997) | 2026 | name in abstract: V184 |
| PMID 38724547 | Characteristics of drug resistance mutations in ART-experienced HIV-1 patients with low-level viremia in Zhengzhou City, China. | Scientific reports | 2024 | name in abstract: V184 |
| PMID 19109381 | Reduced viral replication capacity of human immunodeficiency virus type 1 subtype C caused by cytotoxic-T-lymphocyte escape mutations in HLA-B57 epitopes of capsid protein. | Journal of virology | 2009 | name in abstract: V184 |
| PMID 12843079 | Fluorescent dye terminator sequencing methods for quantitative determination of replication fitness of human immunodeficiency virus type 1 containing the codon 74 and 184 mutations in reverse transcriptase. | Journal of clinical microbiology | 2003 | name in abstract: V184 |
| PMID 21149010 | The white-rot fungus Pleurotus ostreatus secretes laccase isozymes with different substrate specificities. | Mycologia | 2003 | name in abstract: V184 |
| PMID 11594690 | Early detection of mixed mutations selected by antiretroviral agents in HIV-infected primary human lymphocytes. | Antiviral chemistry & chemotherapy | 2001 | name in abstract: V184 |
| PMID 9021181 | Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene. | Antimicrobial agents and chemotherapy | 1997 | name in abstract: V184 |
Notes
Live recombinant Schwarz-strain measles virus with an extra transcription unit encoding the chikungunya structural polyprotein. Included because a phase 3 trial was authorised and run (Themis, Belgian sites); Merck, which acquired Themis in 2020, later dropped the chikungunya programme. Merck code V184.
How to cite
MV-CHIK (AXP000208.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000208.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.